Federal Trade Commission v. Schering-Plough Corp.
548 U.S. 919, 126 S. Ct. 2929, 165 L. Ed. 2d 977, 74 U.S.L.W. 3722, 2006 WL 1725862, 2006 U.S. LEXIS 5128
Opinion
FEDERAL TRADE COMMISSION
v.
SCHRTINH-PLOUGH CORP. ET AL.
Supreme Court of United States.
Motions of Henry A. Waxman, National Association of Chain Drug Stores, Public Patent Foundation, Bayer Corporation, and AARP and Prescription Access Litigation Project for leave to file briefs as amici curiae granted. Certiorari denied. JUSTICE BREYER took no part in the consideration or decision of these motions and this petition.
Free access — add to your briefcase to read the full text and ask questions with AI
Federal Trade Commission v. Schering-Plough Corp., 548 U.S. 919, 126 S. Ct. 2929, 165 L. Ed. 2d 977, 74 U.S.L.W. 3722, 2006 WL 1725862, 2006 U.S. LEXIS 5128 (2006).
548 U.S. 919 (Federal Trade Commission v. Schering-Plough Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
In Re K-Dur Antitrust Litigation
686 F.3d 197 (Third Circuit, 2012)
In Re Ciprofloxacin Hydrochloride Antitrust Lit.
544 F.3d 1323 (Federal Circuit, 2008)
Arkansas Carpenters Health & Welfare Fund v. Bayer AG
544 F.3d 1323 (Federal Circuit, 2008)